MG
BIO icon

Mather Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mather Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Hold
58
– – ﹤0.01% 1367
2026
Q1 		$16.2K Buy
+58
New +$16.7K ﹤0.01% 1334
2025
Q4 		– Sell
-58
Closed -$16.3K – 761
2025
Q3 		$16.3K Buy
+58
New +$15.8K ﹤0.01% 1162
2025
Q2 		– Sell
-311
Closed -$75.7K – 732
2025
Q1 		$75.7K Sell
311
-150
-33% -$45.1K ﹤0.01% 820
2024
Q4 		$151K Buy
461
+292
+173% +$99.1K ﹤0.01% 650
2024
Q3 		$56.5K Sell
169
-191
-53% -$60.7K ﹤0.01% 856
2024
Q2 		$125K Buy
360
+100
+38% +$29.1K ﹤0.01% 745
2024
Q1 		$84K Buy
+260
New +$85.5K ﹤0.01% 754
2023
Q2 		– Sell
-520
Closed -$249K – 622
2023
Q1 		$249K Buy
520
+3
+0.6% +$1.4K ﹤0.01% 436
2022
Q4 		$217K Buy
+517
New +$209K ﹤0.01% 449
2022
Q3 		– Sell
-421
Closed -$208K – 471
2022
Q2 		$208K Buy
421
+44
+12% +$22.9K ﹤0.01% 361
2022
Q1 		$212K Buy
377
+24
+7% +$14.5K ﹤0.01% 419
2021
Q4 		$267K Sell
353
-15
-4% -$11.2K 0.01% 317
2021
Q3 		$275K Sell
368
-20
-5% -$15K 0.01% 236
2021
Q2 		$250K Sell
388
-5
-1% -$3.04K 0.01% 239
2021
Q1 		$224K Buy
393
+1
+0.3% +$592 0.01% 241
2020
Q4 		$229K Buy
392
+3
+0.8% +$1.71K 0.01% 220
2020
Q3 		$201K Buy
+389
New +$197K 0.01% 232

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mather Group's BIO Position: Q2 2026 in Review

Mather Group held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 58 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Mather Group first reported a position in BIO in Q3 2020 and has held it in 18 quarters since. The position peaked at $275K in Q3 2021. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Mather Group held 58 shares of Bio-Rad Laboratories Class A worth $17K as of Q2 2026.
  • Mather Group left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1367 holding.
  • Mather Group first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and has held it in 18 quarters since.
  • Mather Group's Bio-Rad Laboratories Class A position peaked at $275K in Q3 2021.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.